Fulgent Genetics (FLGT) Current Assets (2015 - 2026)

Fulgent Genetics has disclosed Current Assets across 12 years of filings, most recently posting $454.8 million for Q2 2026.

• In Q2 2026, Current Assets rose 6.07% year-over-year to $454.8 million; the TTM figure through Jun 2026 stood at $454.8 million (up 6.07% YoY), while the FY2025 annual figure was $550.5 million, up 55.69% from the prior year.
• Current Assets came in at $454.8 million for Q2 2026 at Fulgent Genetics, down from $479.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $765.3 million in Q1 2022 to a low of $326.5 million in Q3 2024.
• Average Current Assets over 5 years is $513.0 million, with a median of $507.6 million recorded in 2023.
• Year-over-year, Current Assets plunged 40.61% in 2024 and jumped 55.69% in 2025.
• Over 5 years, Current Assets stood at $627.9 million in 2022, then retreated by 19.12% to $507.8 million in 2023, then sank by 30.38% to $353.6 million in 2024, then surged by 55.69% to $550.5 million in 2025, then slipped by 17.39% to $454.8 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $454.8 million in Q2 2026, $479.0 million in Q1 2026, and $550.5 million in Q4 2025.